1. Home
  2. SLS vs MFIN Comparison

SLS vs MFIN Comparison

Compare SLS & MFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • MFIN
  • Stock Information
  • Founded
  • SLS 2012
  • MFIN 1995
  • Country
  • SLS United States
  • MFIN United States
  • Employees
  • SLS N/A
  • MFIN N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • MFIN Finance: Consumer Services
  • Sector
  • SLS Health Care
  • MFIN Finance
  • Exchange
  • SLS Nasdaq
  • MFIN Nasdaq
  • Market Cap
  • SLS 238.7M
  • MFIN 243.9M
  • IPO Year
  • SLS N/A
  • MFIN 1996
  • Fundamental
  • Price
  • SLS $1.92
  • MFIN $9.89
  • Analyst Decision
  • SLS Strong Buy
  • MFIN Strong Buy
  • Analyst Count
  • SLS 1
  • MFIN 1
  • Target Price
  • SLS $7.00
  • MFIN $12.00
  • AVG Volume (30 Days)
  • SLS 4.7M
  • MFIN 32.1K
  • Earning Date
  • SLS 11-12-2025
  • MFIN 10-29-2025
  • Dividend Yield
  • SLS N/A
  • MFIN 4.86%
  • EPS Growth
  • SLS N/A
  • MFIN N/A
  • EPS
  • SLS N/A
  • MFIN 1.75
  • Revenue
  • SLS N/A
  • MFIN $332,256,000.00
  • Revenue This Year
  • SLS N/A
  • MFIN N/A
  • Revenue Next Year
  • SLS N/A
  • MFIN $1.53
  • P/E Ratio
  • SLS N/A
  • MFIN $5.64
  • Revenue Growth
  • SLS N/A
  • MFIN 16.48
  • 52 Week Low
  • SLS $0.77
  • MFIN $7.71
  • 52 Week High
  • SLS $2.48
  • MFIN $10.98
  • Technical
  • Relative Strength Index (RSI)
  • SLS 51.34
  • MFIN 46.47
  • Support Level
  • SLS $1.86
  • MFIN $9.85
  • Resistance Level
  • SLS $2.06
  • MFIN $10.29
  • Average True Range (ATR)
  • SLS 0.16
  • MFIN 0.29
  • MACD
  • SLS -0.02
  • MFIN 0.02
  • Stochastic Oscillator
  • SLS 11.90
  • MFIN 58.42

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About MFIN Medallion Financial Corp.

Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.

Share on Social Networks: